Wednesday, August 5, 2020

Yemen's Multilayered War: Al Qaeda in Arab Peninsula

This article is by

Share this article

Article Contributor(s)

Anant Jani

Article Title

Yemen's Multilayered War: Al Qaeda in Arab Peninsula

Publisher

Global Views 360

Publication Date

August 5, 2020

URL

Sailors render honors at the USS Cole Memorial

Sailors render honors at the USS Cole Memorial | Source: Flickr

This is the 4th part of a short explainer article series on the current crisis in Yemen. To read the earlier parts of the series click on the following links.

To read the 1st part of the series click on the link.

To read the 2nd part of the series click on the link.

To read the 3rd part of the series click on the link.

The unification of Yemen in 1990 was a direct result of the military defeat of South Yemen at the hand of North Yemen forces. This military defeat and coerced unification implied that Unified Yemen could not achieve real cohesion, preventing the functioning of the nation as a democratic unit.

Meanwhile, newer elements were added to the dangerous mix of sub-nationalism, intra religious division, and tribal loyalty in Yemen. These were the Yemeni veterans of Soviet-Afghan war who fought with the Afghan mujahideen against the Soviet army backing the Afghan government.

These were hardline Wahabi and Salafi fighters, following an idealogy that mandated a strict interpretation of Islam. The fighters returned to Yemen in the early 1990s, after the withdrawal of Soviet forces from Afghanistan. The local Yemeni, both the Zaidi Shias or Maliki Sunni have traditionally followed a more liberal version of Islamic and social practices. Unlike the local Sunnis who were living in peaceful coexistence with the Zaidis Shia, these hardliners were antagonistic to the Shias.

Their arrival was followed by a forceful realignment of the local residents’ religious practices, mandating the local population to strict interpretations and social practices. Osama bin Laden, who had family roots in Yemen, was a conveniently placed ideological mentor. This led to a pushback from both the government forces as well as Shia groups, especially the Houthi-led Ansar Allah movement. In time, these former mujahideen, who were battle hardened and well versed in guerilla warfare, allied themselves with Al-Qaeda to start a low level insurgency in Yemen.

The Gulf war and subsequent stationing of American forces in Saudi Arabia and other gulf countries provided another impetus for the growth of Al Qaeda in Yemen. Consequently, they demanded that coalition forces leave Arabian land, failing which would result in more terror attacks.

Al-Qaeda affiliated groups attacked many installations associated with the US-led coalition forces in Yemen and nearby countries. The most successful of those was the famous bombing of USS Cole in Aden, in 2000. It was followed by a series of attacks leading up to  9/11.

Al-Qaeda in the Arab Peninsula (AQAP) is also known as the Ansar al-Sharia in Yemen is fighting to set up an emirate amidst the lack of leadership post the Houthi rebellion. It was this outfit that claimed responsibility for the attack on the French satirical magazine, Charlie Hebdo, in 2015 and is now considered the most dangerous al-Qaeda outfit by the US.

The CNN reported that “AQAP set out its objectives in a May 2010 statement as the "expulsion of Jews and crusaders" from the Arabian Peninsula, the re-establishment of the Islamic caliphate, the introduction of Sharia, or Islamic law, and the liberation of Muslim lands.”

The full list of attacks and places captured by terrorist insurgents in chronological order can be accessed here.

One of the outcomes of continual terrorist attacks has been a reduction in Hadi’s popularity. He is also seen as weak for not being able to stop al-Qaeda from terrorising Southern Yemen, as well as for not being able to alleviate them from their feeling of marginalization ever since the unification.

To read the 5th part of the series click on the link.

Subscribe to the Global Views 360 mailing list for the weekly updates.

Support us to bring the world closer

To keep our content accessible we don't charge anything from our readers and rely on donations to continue working. Your support is critical in keeping Global Views 360 independent and helps us to present a well-rounded world view on different international issues for you. Every contribution, however big or small, is valuable for us to keep on delivering in future as well.

Support Us

Share this article

Read More

February 4, 2021 5:14 PM

Asian countries & the race for COVID-19 Vaccine

Our relationship with the new strain of coronavirus is almost 8 months strong now. Countries like the US, Russia, UK, China, India, and many more have already set their brainy scientists in the task of developing a vaccine, turning it into a race which desperately needs a winner, since no one wants this deadly relationship to endure. Several attempts have proved to be successful, especially in countries like Russia, USA, India, and China.

China was the first to start scouring for a vaccine the day WHO declared that the new strain of SARS-CoV, originating in Wuhan-China, has resulted in a pandemic. It is a fierce competitor, especially to the US, as almost 8 of the 24 promising vaccines approved for clinical trials are from China. It used the technology of ‘inactivated vaccine’ which basically means killing the actual virus and using that to create a vaccine. This method is quite useful in treating measles and influenza, thus, increasing the chances of success in the case of COVID-19 as well.

“It’s a tried and true strategy”, Paul Offit, director of the Vaccine Education Center at Children’s Hospital of Philadelphia, said  about the inactivated vaccine. One potential vaccine from China-based Sinopharm is already in the phase 3 of trials whereas Sinovac will enter the third phase this month. Moreover, China has permitted Sinovac and Sinopharm to dilute phase 1 and 2 of vaccine trials on humans to hasten the process.

The head of the Chinese Center for Disease Control and Prevention, Gao Fu, had also been injected with a potential vaccine on July 28, 2020. “I’m going to reveal something undercover: I am injected with one of the vaccines'' Gao Fu said in a webinar hosted by Alibaba Health, an arm of the Chinese e-commerce giant, and Cell Press, an American publisher of scientific journals. However, he did not reveal any more details about how and when exactly he administered himself with the vaccine and ‘hopes’ that the vaccine works.

Vladimir Putin, President of Russia | Source: Wikimedia

Elsewhere in Russia, on August 11, 2020, President Vladimir Putin proudly announced that Russia was the first country to grant regulatory approval to their vaccine after carrying out human trials for less than 2 months by the Gamalei Institute in Moscow. Regulatory approval permits vaccination of the masses. Although it has not undergone phase 3 of trials, Russia expects to initiate mass production of the vaccine by the end of this year. Kirill Dmitriev, head of Russia's sovereign wealth fund states that the vaccine will be called ‘Sputnik V’, named after Sputnik 1, the first satellite launched by Soveit Union which was a euphoric moment for Russia. More recently, China and Russia have joined hands in proceeding with the clinical trials of their vaccines.

These two instances seem to bring a new hope for the future, yet raise alarms and invite scepticism from the experts in the field of public health. One major concern is that without prolonged trials, vaccines should not be authorized for public use. Anthony Fauci, an infectious disease expert based in the US said “I do hope the Chinese and the Russians are actually testing the vaccines before they are administering the vaccine to anyone. Because claims of having a vaccine ready to distribute before you do testing is problematic at the very least”. Hence, some people are still in doubt regarding the safety of the product. Putin, however, rubbished such concerns and said "I know that it works quite effectively, forms strong immunity, and I repeat, it has passed all the needed checks".

An Indian biotechnological company, Bharat Biotech developed ‘Covaxin’ in collaboration with Indian Council for Medical Research (ICMR), using the mechanism of inactivated vaccine. It was successful in getting approval for human trials which were scheduled to begin in July, 2020. Initial reports stated that it would be ready for mass use by August 15, 2020, which also marked the 73rd Independence Day of India. However, Bharat biotech was clear in letting the public know that phase 1 of the trials are still on-going. ICMR cleared the confusion by stating that it would prepare the results of the phase 1 trials by August 15, 2020, not the actual vaccine for use. Phase 2 of the trials are awaited in September, 2020.

So far, the results of phase 1 trials have been positive as no serious side-effects are observed in the vaccine candidates. “The vaccine has been safe. No adverse effect has been reported. Even the point of injection pain, which is normal in vaccines, has been very mild” said Dr Kushwaha of Prakhar Hospital.

Meanwhile, the South Korean government stated on August 21, 2020, that it will secure adequate vaccine supply to its citizens by cooperating with international bodies and promoting local drug development. Three South Korean companies have started the process of making a vaccine and all are in the clinical trial phase. Bill Gates asserts that the South Korean pharmaceutical company, SK Bioscience, will have around 200 million vaccine doses ready by June 2021.

Japan is jointly collaborating with the UK, France and other European countries to establish a $20 billion fund to buy coronavirus vaccines, with Japan pledging a contribution of $800 million. It’s vaccine program aims to focus on giving primary attention to its medical workers and the elderly people of the country when the first doses of the vaccine are made. The state-funded vaccination program is believed to be officially adopted by Japan in September this year with negotiations with the UK and US based drug makers already in place.

With the race to bring COVID-19 vaccine seemingly coming to a close and it will hopefully be ready by the end of 2020 or early 2021. Till then, the entire world is watching this race with bated breath.

Read More